TSE:4519Pharmaceuticals
Chugai Pharmaceutical (TSE:4519) Valuation After Strong Earnings And Enhanced Dividend Plans
Chugai Pharmaceutical (TSE:4519) has drawn fresh attention after reporting higher full year 2025 sales, revenue, and net income, along with plans for an increased year end dividend and a separate special dividend.
See our latest analysis for Chugai Pharmaceutical.
The earnings release and richer dividend plans appear to have been met positively, with a 1 day share price return of 6.02% bringing Chugai Pharmaceutical to ¥9,126. That builds on a 30 day share price return of 8.37% and a 1 year...